TG Therapeutics (TGTX) Earnings Date & Reports

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

TGTX is expected to report earnings to rise 177.67% to 33 cents per share on August 10

TG Therapeutics TGTX Stock Earnings Reports

Q2'26

Est.

$0.33

Q1'26

Missed

by $0.16

Q4'25

Missed

by $0.23

Q3'25

Beat

by $2.21

Q2'25

Missed

by $0.02

The last earnings report on May 06 showed earnings per share of 11 cents, missing the estimate of 28 cents. With 752.90K shares outstanding, the current market capitalization sits at 8.33B.

View a ticker or compare two or three

Compare

TGTX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for TGTX